BIOMAT Database Logo BIOMAT Database Logo

Design, synthesis and biological evaluation of novel diarylpyridine derivatives as tubulin polymerisation inhibitors. 2022

Shanbo Yang, and Chao Wang, and Lingyu Shi, and Jing Chang, and Yujing Zhang, and Jingsen Meng, and Wenjing Liu, and Jun Zeng, and Renshuai Zhang, and Yingchun Shao, and Dongming Xing
The Affiliated Hospital of Qingdao University, Cancer Institute, School of Basic Medicine, Qingdao University, Qingdao, China.

A set of novel diarylpyridines as anti-tubulin agents were designed, synthesised using a rigid pyridine as a linker to fix the cis-orientation of ring-A and ring-B. All of the target compounds were evaluated for their in vitro antiproliferative activities. Among them, 10t showed remarkable antiproliferative activities against three cancer cell lines (HeLa, MCF-7 and SGC-7901) in sub-micromolar concentrations. Consistent with its potent antiproliferative activity, 10t also displayed potent anti-tubulin activity. Cellular mechanism investigation elucidated 10t disrupted the cellular microtubule structure, arrested cell cycle at G2/M phase and induces apoptosis. Molecular modelling studies showed that 10t could bind to the colchicine binding site on microtubules. These results provide motivation and further guidance for the development of new CA-4 analogues.

UI MeSH Term Description Entries
D011725 Pyridines Compounds with a six membered aromatic ring containing NITROGEN. The saturated version is PIPERIDINES.
D003078 Colchicine A major alkaloid from Colchicum autumnale L. and found also in other Colchicum species. Its primary therapeutic use is in the treatment of gout, but it has been used also in the therapy of familial Mediterranean fever (PERIODIC DISEASE). Colchicine, (+-)-Isomer,Colchicine, (R)-Isomer
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004354 Drug Screening Assays, Antitumor Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals. Anticancer Drug Sensitivity Tests,Antitumor Drug Screens,Cancer Drug Tests,Drug Screening Tests, Tumor-Specific,Dye Exclusion Assays, Antitumor,Anti-Cancer Drug Screens,Antitumor Drug Screening Assays,Tumor-Specific Drug Screening Tests,Anti Cancer Drug Screens,Anti-Cancer Drug Screen,Antitumor Drug Screen,Cancer Drug Test,Drug Screen, Anti-Cancer,Drug Screen, Antitumor,Drug Screening Tests, Tumor Specific,Drug Screens, Anti-Cancer,Drug Screens, Antitumor,Drug Test, Cancer,Drug Tests, Cancer,Screen, Anti-Cancer Drug,Screen, Antitumor Drug,Screens, Anti-Cancer Drug,Screens, Antitumor Drug,Test, Cancer Drug,Tests, Cancer Drug,Tumor Specific Drug Screening Tests
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D014404 Tubulin A microtubule subunit protein found in large quantities in mammalian brain. It has also been isolated from SPERM FLAGELLUM; CILIA; and other sources. Structurally, the protein is a dimer with a molecular weight of approximately 120,000 and a sedimentation coefficient of 5.8S. It binds to COLCHICINE; VINCRISTINE; and VINBLASTINE. alpha-Tubulin,beta-Tubulin,delta-Tubulin,epsilon-Tubulin,gamma-Tubulin,alpha Tubulin,beta Tubulin,delta Tubulin,epsilon Tubulin,gamma Tubulin
D015195 Drug Design The molecular designing of drugs for specific purposes (such as DNA-binding, enzyme inhibition, anti-cancer efficacy, etc.) based on knowledge of molecular properties such as activity of functional groups, molecular geometry, and electronic structure, and also on information cataloged on analogous molecules. Drug design is generally computer-assisted molecular modeling and does not include PHARMACOKINETICS, dosage analysis, or drug administration analysis. Computer-Aided Drug Design,Computerized Drug Design,Drug Modeling,Pharmaceutical Design,Computer Aided Drug Design,Computer-Aided Drug Designs,Computerized Drug Designs,Design, Pharmaceutical,Drug Design, Computer-Aided,Drug Design, Computerized,Drug Designs,Drug Modelings,Pharmaceutical Designs
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular

Related Publications

Shanbo Yang, and Chao Wang, and Lingyu Shi, and Jing Chang, and Yujing Zhang, and Jingsen Meng, and Wenjing Liu, and Jun Zeng, and Renshuai Zhang, and Yingchun Shao, and Dongming Xing
Design, synthesis and biological evaluation of novel thiazole-naphthalene derivatives as potential anticancer agents and tubulin polymerisation inhibitors.
December 2021, Journal of enzyme inhibition and medicinal chemistry,
Shanbo Yang, and Chao Wang, and Lingyu Shi, and Jing Chang, and Yujing Zhang, and Jingsen Meng, and Wenjing Liu, and Jun Zeng, and Renshuai Zhang, and Yingchun Shao, and Dongming Xing
Design, synthesis and biological evaluation of novel pyrazoline-containing derivatives as potential tubulin assembling inhibitors.
April 2015, European journal of medicinal chemistry,
Shanbo Yang, and Chao Wang, and Lingyu Shi, and Jing Chang, and Yujing Zhang, and Jingsen Meng, and Wenjing Liu, and Jun Zeng, and Renshuai Zhang, and Yingchun Shao, and Dongming Xing
Design, synthesis and biological evaluation of novel dihydroquinolin-4(1H)-one derivatives as novel tubulin polymerization inhibitors.
December 2023, European journal of medicinal chemistry,
Shanbo Yang, and Chao Wang, and Lingyu Shi, and Jing Chang, and Yujing Zhang, and Jingsen Meng, and Wenjing Liu, and Jun Zeng, and Renshuai Zhang, and Yingchun Shao, and Dongming Xing
Design, synthesis and biological evaluation of colchicine derivatives as novel tubulin and histone deacetylase dual inhibitors.
May 2015, European journal of medicinal chemistry,
Shanbo Yang, and Chao Wang, and Lingyu Shi, and Jing Chang, and Yujing Zhang, and Jingsen Meng, and Wenjing Liu, and Jun Zeng, and Renshuai Zhang, and Yingchun Shao, and Dongming Xing
Design, synthesis and evaluation of dihydro-1H-indene derivatives as novel tubulin polymerisation inhibitors with anti-angiogenic and antitumor potency.
December 2023, Journal of enzyme inhibition and medicinal chemistry,
Shanbo Yang, and Chao Wang, and Lingyu Shi, and Jing Chang, and Yujing Zhang, and Jingsen Meng, and Wenjing Liu, and Jun Zeng, and Renshuai Zhang, and Yingchun Shao, and Dongming Xing
Design, Synthesis, and Biological Evaluation of Novel Dihydropyrimidinone Derivatives as Potential Anticancer Agents and Tubulin Polymerization Inhibitors.
January 2023, Assay and drug development technologies,
Shanbo Yang, and Chao Wang, and Lingyu Shi, and Jing Chang, and Yujing Zhang, and Jingsen Meng, and Wenjing Liu, and Jun Zeng, and Renshuai Zhang, and Yingchun Shao, and Dongming Xing
Design, synthesis and biological evaluation of novel indole-based oxalamide and aminoacetamide derivatives as tubulin polymerization inhibitors.
January 2020, Bioorganic & medicinal chemistry letters,
Shanbo Yang, and Chao Wang, and Lingyu Shi, and Jing Chang, and Yujing Zhang, and Jingsen Meng, and Wenjing Liu, and Jun Zeng, and Renshuai Zhang, and Yingchun Shao, and Dongming Xing
Design, synthesis and biological evaluation of novel acridine and quinoline derivatives as tubulin polymerization inhibitors with anticancer activities.
September 2021, Bioorganic & medicinal chemistry,
Shanbo Yang, and Chao Wang, and Lingyu Shi, and Jing Chang, and Yujing Zhang, and Jingsen Meng, and Wenjing Liu, and Jun Zeng, and Renshuai Zhang, and Yingchun Shao, and Dongming Xing
Design, synthesis and biological evaluation of novel imidazole-chalcone derivatives as potential anticancer agents and tubulin polymerization inhibitors.
July 2021, Bioorganic chemistry,
Shanbo Yang, and Chao Wang, and Lingyu Shi, and Jing Chang, and Yujing Zhang, and Jingsen Meng, and Wenjing Liu, and Jun Zeng, and Renshuai Zhang, and Yingchun Shao, and Dongming Xing
Design, synthesis, and biological evaluation of novel diphenylamine derivatives as tubulin polymerization inhibitors targeting the colchicine binding site.
July 2022, European journal of medicinal chemistry,
Copied contents to your clipboard!